A study of mice and human cells provides insight into how genes and environment can interact to induce preterm birth. The findings hint at new ways to treat women at risk for this condition.
Very little is known about why some babies-about one in ten worldwide-are born prematurely. Many factors can contribute, including genetic predisposition, increased maternal age, infection and inflammation, and oxidative stress. The relative contributions of the various factors and their interactions are a black box.
To begin to study such questions, Yasushi Hirota and his colleagues had previously developed a mouse model of preterm birth. These mice have a uterine deletion of Trp53, which encodes the tumor suppressor protein p53.
About half of these mice undergo spontaneous preterm birth, a phenotype that has been traced to premature senescence of the decidua, the endometrial stromal tissue that is modified during gestation. Drugs that counteract decidual senescence, such as rapamycin, which targets the senescence-associated signaling molecule mTORC1, are effective in this mouse model.
In the new study, Jeeyeon Cha et al. exposed these mice to a mild inflammatory insult with lipopolysaccharide (LPS), which provoked preterm birth in 100 percent of the animals. The combination of genetic and environmental insult affected the decidua and increased inflammation, as indicated by prostaglandin synthesis, and it also quelled production of progesterone by the ovary. Even a small amount of LPS trigged a drop in serum levels of progesterone, an effect only observed at high doses of LPS in wild-type animals. The researchers could prevent preterm birth in the mice without inducing adverse effects in the mothers or their offspring by treatment with both rapamycin and progesterone.
Progesterone is sometimes used clinically to fend off preterm birth, though its effectiveness is limited and only some women benefit. The therapeutic potential of combinations of progesterone with other agents, such as rapamycin, may be a fruitful avenue of investigation. The researchers' observations in human cells support this approach; for instance, they observed higher mTORC1 signaling in decidua of mothers who had given birth prematurely. Moreover, adding progesterone or rapamycin or both to cultured human decidual cells quelled the inflammatory response to LPS.
Exactly how p53 deletion and LPS signaling interact to yield effects on the decidua and ovarian secretion of progesterone is, as yet, unclear. But the researchers suggest that a healthy decidua is key to proper birth timing, particularly since the decidua may in turn signal the ovary. The composition of the bacteria in the gut may help explain why females are more susceptible to autoimmune diseases than males, a study in mice suggests. The findings highlight the complex ways that sex hormones interact with the immune system, an increasingly recognized area of biological research that was highlighted this July at the Annual Meeting of the Society for the Study of Reproduction (SSR 2013) in Montréal.
In the new study, Alexander Chervonsky and colleagues took a close look at non-obese diabetic (NOD) mice, which model type 1 diabetes, an autoimmune disorder. Previous studies had shown that female NOD mice are more susceptible to disease than male NOD mice. Curiously, NOD mice raised in germ-free facilities, lacking gut bacteria, are at much greater risk for disease, with the males almost as susceptible as the females. The researchers sought to tease out the relationships between hormonal and microbial influences on disease.
Chervonsky et al. now report that the gut microbiota differ between male and female NOD mice, and that castrating the males results in the microbiota taking on the female composition [1] . The researchers also found that some defined microbial communities, inoculated into germfree NOD mice, could protect males-but not females-against diabetes. The protective effect required testosterone to be present, but the level of protection did not correlate with the level of testosterone in the blood.
The findings suggest that a threshold level of testosterone is needed for microbes to exert their protective effect, and that hormones and microbes work together to trigger protective pathways. Although the mechanisms are likely to be complex, the findings also hint that the cytokine interferon-gamma may help mediate protection in males. This study may provide insight into why autoimmune diseases are about 80 percent more common in women than men.
Not only are women more susceptible to autoimmune diseases, but their response to infection also differs from that of men. This is an area studied by Sabra Klein, who spoke at SSR 2013. She notes that women have more pronounced responses to vaccines than men and are known to report worse symptoms when they are infected with an influenza virus. Such observations jibe with numerous studies suggesting sex-specific differences in immune responses-perhaps not surprising, given that immune cells have receptors for estrogen and other hormones.
At the meeting, Klein highlighted her work showing that influenza infection in female mice prompts a heightened pro-inflammatory response, compared to male mice [2] . The inflammatory response can be protective, shielding against infection, but when it is overamplified, disease can worsen. In her studies, some previously published [3] , Klein found that treating flu-infected mice treated with estradiol or agonists of the estrogen receptor eases the inflammatory response and illness from flu. As with autoimmune diseases, continuous (as opposed to cyclical) low levels of estrogen seem to dampen the inflammatory responses and protect against tissue damage and even death.
Klein notes that the public health and biomedical research communities have not fully absorbed the lessons of these and other studies. She says it is important for researchers doing animal studies to include both males and females and to stratify their data by sex. This is a lesson that is also beginning to be applied by researchers who study other areas of biology, such as metabolism. For instance, at SSR 2013, Sky Feuer, Paolo Rinaudo, and colleagues showed that fat tissue and, to a lesser extent, liver tissue exhibit sexual dimorphism in the types of metabolites they express [4] . A key event in the oocyte-to-embryo transition is the completion of meiosis and the initiation of mitosis. Drosophila researchers have now shown how precise regulation of the levels of a protein called Matrimony is required for this transition to mitosis. During meiosis, Matrimony is present at high levels and restrains the activity of Polo kinase, which is involved in processes such as chromosome segregation, centrosome dynamics, and cytokinesis.
Matrimony for the Oocyte
The oocyte is packed full of proteins (deposited during oogenesis) that drive the initial mitotic divisions of the embryo. For these mitotic proteins to function properly, Zachary Whitfield et al. speculated that the handoff from meiosis to mitosis requires degradation of certain proteins specific to meiosis. The researchers identified a protein called Matrimony, present at high levels only during meiosis, which appears to fulfill this function.
The researchers homed in on Matrimony by looking for proteins in immunoprecipitation assays that interacted with Cort, a female, meiosis-specific activator of APC/C. APC/C is responsible for targeting certain proteins for degradation during both mitosis and meiosis, and Matrimony seems to be one of the substrates of Cortactivated APC/C (APC cort ). APC cort is required for the degradation of Matrimony, enabling the oocyte to transition to mitotic cell divisions: overexpression of Matrimony in the early embryo causes aberrant nuclear divisions and developmental defects.
Matrimony is known to be an inhibitor of Polo kinase, and decreasing levels of Polo activity enhances the defects seen by overexpression of Matrimony. Whether a similar regulatory process occurs in mammals is unclear, though in mice, the levels of APC/C are known to be carefully regulated during meiosis, and some of the players involved have been identified.
In the future, experiments on other proteins that interact with APC cort could yield other regulators of the oocyte-to-embryo transition.
Whitfield ZJ, Chisholm J, Hawley RS, Orr-Weaver TL. A meiosis-specific form of the APC/C promotes the oocyte-to-embryo transition by decreasing levels of the Polo kinase inhibitor Matrimony. PLoS Biol 2013; 11(9):e1001648. Germ cells have to balance many responsibilities: they must perform highly specialized tasks such as migration and meiosis, while maintaining the ability to form a totipotent zygote-a cell that can generate any other cell type-at fertilization. Bluma Lesch et al. now show that germ cells accomplish this balancing act by keeping a set of developmentally important genes in a ''poised'' state, silent but ready to fire.
Germ Cells Stay Flexible
The researchers examined mouse germ cells at various stages of development, performing high-resolution, genome-wide analysis of the state of their chromatin using ChIP-seq and RNA-seq. They identified a class of genes that localized to sites on chromatin with high levels of both an activating histone modification (H3K4me3) and a repressive modification (H3K27me3). This combined state is known to keep genes poised to quickly undergo transcriptional modification, either activation or repression, in the presence of developmental signals.
This set of 92 genes is highly enriched for regulators of development and organogenesis, and is similar between male and female gametes. Moreover, these genes are kept in this state through multiple germ cell stages, from the primordial germ cell through meiosis, and, in the males, into post-meiotic stages (female gametes were not tested at this late stage).
The researchers are currently testing whether the genes in this set also have these modifications in mature sperm and oocytes during fertilization and in the early embryo. The data show how maintaining a flexible chromatin state gives the specialized germ cell the capability of spawning perhaps the most adaptable cell in biology, the totipotent zygote. 
